LexDanaLexDanabeta
Inventor

OLIVIER LABEEUW

Inventor
FR

Overview

3→
Patents
2021–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds27%
C07BGeneral methods of organic chemistry18%
PatentTitleYear
12,134,608Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands202411,306,069Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands202211,179,329Therapeutical use of H3-ligands2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021Patents assigned to BIOPROJET PHARMA (1)· patent assignee history
2021–2024Based in FR· patent location history
2022–2024Patents assigned to BIOPROJET SOC CIV (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOPROJET SOC CIV22022–2024
BIOPROJET PHARMA12021
Locations
LocationPatentsSpan
FR32021–2024